Targeted genomic CRISPR-Cas9 screen identifies MAP4K4 as essential for glioblastoma invasion

por Prolo, Laura M., Li, Amy, Owen, Scott F., Parker, Jonathon J., Foshay, Kara, Nitta, Ryan T., Morgens, David W., Bolin, Sara, Wilson, Christy M., Vega L, Johana C. M., Luo, Emily J., Nwagbo, Gigi, Waziri, Allen, Li, Gordon, Reimer, Richard J., Bassik, Michael C., Grant, Gerald A.
Publicado 2019